If you are interested in supporting an individual cancer research program at Fred Hutch, you may direct your gift to that area of interest. Private support provides seed money to fund our innovative research that can accelerate breakthroughs in cancer prevention, detection and treatment.
Primary brain tumors form in brain tissue because of abnormal cell growth and can occur in several different forms. Our researchers are investigating brain cancer’s causes, with the goal of translating that knowledge into more effective treatments and prevention measures.
Our scientists are reducing breast cancer incidence and death by identifying risk factors for the disease, developing new methods of detection and helping to predict health outcomes based on the patient's genetics and other factors.
Colorectal cancer ranks as the third most commonly diagnosed — and second-deadliest — form of cancer in the United States. Our researchers are investigating ways to detect colon cancer early, when it is most treatable, by improving screening tests.
Fred Hutch plays a leading role in identifying esophageal cancer’s causes, laying the foundation for new ways to prevent the disease and improve patient care and quality of life.
Fred Hutch is revolutionizing the way cancer is treated and cured. Our researchers are developing new ways to empower a patient’s own immune system to do what it does naturally — fight disease.
Fred Hutch pioneered one of the most effective leukemia treatments: bone marrow transplantation. We are also advancing other key treatments, including stem cell and cord blood transplantation, immunotherapy, and drugs that destroy cancer cells.
Our scientists are studying how lifestyle factors like smoking and exercise are related to lung cancer. Their research led to the discovery of proteins in the blood that are associated with early lung cancer development and could lead to a blood test to detect the disease.
Lymphoma strikes the lymphatic system, a key part of the immune system. Fred Hutch pioneered bone marrow transplantation as a treatment for lymphoma, leukemia and other cancers, and our scientists are developing promising new therapies, such as cord blood transplantation.
More than two-thirds of multiple myeloma diagnoses occur in patients 65 and older. Fred Hutch researchers pioneered the mini-transplant, which reduces the amount of radiation to a minimal dose and is a better option for older patients or those who might not be able to withstand conventional transplants.
Hutch researchers pioneered one of the most significant breakthroughs in pancreatic cancer research in decades: a genetically engineered mouse model that exactly mimics human pancreatic cancer. The model is widely used in research around the world and has led to new treatments and diagnostic tests.
Prostate cancer ranks as the most common form of cancer among men in the United States. Fred Hutch researchers are at the forefront of improving how prostate cancer is detected and diagnosed, with the goal of identifying when the disease is truly lethal.